Center for Genomic Regulation in Oklahoma
Official title: Center for Genomic Regulation
Funded at Oklahoma Medical Research Foundation · NIH-11349611 · Data updated 2026-11-12
A multi-year program to build a collaborative genomics research hub in Oklahoma that connects experts to study how genomes are controlled and ultimately improve cancer biology.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oklahoma Medical Research Foundation NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project start | June 10, 2025 |
| Project end | April 30, 2030 |
| Funding year | 2026 |
| Award (this year) | $2,463,036 |
| NIH project number | 5P20GM156711-02 |
| Project ID | NIH-11349611 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with cancer or conditions tied to genomic regulation who may benefit from future translational discoveries.
✕Less likely to help
Direct patient benefit is not immediate; impact will arise from later translational research stemming from the center.
What this research studies
This grant helps Oklahoma researchers create a shared center focused on how chromatin, DNA modifications, genome structure, and transcription are regulated, with four early-career leaders guiding collaborative projects. It supports training and resources to advance genomic regulation research, training new investigators, and establishing a self-sustaining community. The effort aims to accelerate discoveries in cancer biology by linking technology, data, and scientists across institutions.
Why it matters
Potential benefit: Could accelerate new cancer biology insights and training that strengthen patient-focused genomic medicine in Oklahoma.
How similar studies have gone: Past centers have shown that coordinated genomic regulation research can boost collaboration and grant success in cancer biology.
Where this research is happening
-
Oklahoma Medical Research Foundation
Oklahoma City, United States Active
Researchers
- Principal investigator: Freeman, Willard M — Oklahoma Medical Research Foundation
- Study coordinator: Freeman, Willard M
Related research
Other NIH-funded projects on the same topics.
-
Understanding how DIS3L2 helps keep RNA in check to help lupus patients
A physician-scientist team is studying how a watchdog molecule for RNA (DIS3L2) may drive lupus-related immune problems, with the goal of uncovering new paths to treatment.
-
Stem cell mRNA marks and fat-infiltrated aging muscles
Researchers are studying how aging changes muscle at the cellular level, including fat and fibrous tissue buildup, to help keep older adults stronger and more mobile.
-
Tissue research hub for autoimmune diseases to speed up new treatments
A national program is building a centralized tissue core to study autoimmune diseases like lupus, rheumatoid arthritis, Sjögren’s, and psoriatic conditions using advanced single-cell and spatial analysis.
-
Roles of mitochondrial transporters SLC25A22 and SLC25A46 in brain health
This grant studies how two mitochondrial transporters, SLC25A22 and SLC25A46, affect brain metabolism and neurological disorders using fruit-fly models to uncover disease mechanisms.
-
Colon mucus sugars and how they help keep gut bacteria and the colon healthy
Researchers are looking at how sugar-coated mucus made by cells in the front part of the colon helps keep gut bacteria balanced and may protect people with ulcerative colitis or pouch inflammation.
-
Oxidized lipids driving aging-related muscle loss
This project explores how certain lipid molecules that are damaged or modified over time contribute to muscle weakness and loss in older adults, with the goal of identifying new ways to prevent sarcopenia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.